Gilead raises 2026 sales outlook
Gilead raised its 2026 sales outlook. The report also says Biktarvy will be cut 38% under the health insurance program starting in 2028; quarterly adjusted EPS was reported, along with quarterly revenue.
Story updates
09:38:49 PM UTC
SquawkNews
UPDATE 1-ギリアド、26年売上高見通し修正。メディケア、ビクタルビー価格38%引き下げ 四半期の調整後１株当たり利益（ＥＰＳ）は２．５５ドル、売上高は８３億ドルと報告 ２０２６年の売上高見通し